Pfizer Sues Metsera and Novo Nordisk Over $8.5B Obesity-Drug Deal

Pfizer said on Friday it had filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations in declaring the Danish drugmaker’s $8.5 billion bid for the U.S. obesity drug developer to be a superior offer.